In addition, histological analysis of ovarian cancer tumor tissue pre- and post-neoadjuvant chemotherapy (NACT) has shown that chemotherapy can upregulate TILs including CD8, CD4, and CD20 infiltration [26,27,28]. This evidence concerns the gene CD8A and ovarian cancer.